Skip to content

Multimodal Mechanism Study of transcutaneous auricular vagus nerve stimulation in improving globus pharyngeus

Multimodal Mechanism Study of transcutaneous auricular vagus nerve stimulation in improving globus pharyngeus

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2600117862
Enrollment
Unknown
Registered
2026-01-29
Start date
2026-01-30
Completion date
Unknown
Last updated
2026-02-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Globus pharyngeus

Interventions

Sponsors

Nanjing Drum Tower Hospital, Affiliated Hospital of Medical School, Nanjing University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 75 Years

Inclusion criteria

Inclusion criteria: 1. Age 18-75 years, gender-neutral; 2. Meeting the diagnostic criteria of Rome IV GP, i.e., persistent or intermittent non-painful throat choking sensation or foreign body sensation; absence of evidence of gastroesophageal reflux or eosinophilic esophagitis causing the symptoms; absence of major esophageal motility disorders; no structural lesions detected by physical examination, laryngoscopy, or endoscopy; symptoms persisting for >=6 months, meeting the above diagnostic criteria for the past 3 months, with symptom frequency of at least 1 day per week. 3. Total LUMP score >=6 points; 4. Voluntary acceptance of taVNS treatment and related assessments, with signed informed consent form.

Exclusion criteria

Exclusion criteria: 1. Recent (within 3 months) history of throat surgery or radiotherapy/chemotherapy; 2. Severe arrhythmias, heart failure, pacemaker implantation, or other conditions unsuitable for vagus nerve stimulation; 3. Severe mental disorders (e.g., major depressive disorder, schizophrenia) or recent suicidal ideation; 4. Pregnancy or lactation; 5. Severe hypersensitivity to electrical stimulation or auricular skin; 6. Inability to cooperate with follow-up or related examinations; 7. Other circumstances deemed unsuitable by the investigator.

Design outcomes

Primary

MeasureTime frame
The Laryngopharyngeal Measure of Perceived Sensation;Heart Rate Variability;

Secondary

MeasureTime frame
Self-Rating Anxiety Scale;Self-Rating Depression Scale;Pittsburgh Sleep Quality Index;Inflammatory markers;Cytokine;Resting-state functional magnetic resonance imaging;

Countries

China

Contacts

Public ContactXiaoyun Qian

Nanjing Drum Tower Hospital, Affiliated Hospital of Medical School, Nanjing University

qxy522@163.com+86 138 5163 0006

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 7, 2026